21MA044N Immunotherapy: Quantifying The Tumor-Immune Ecosystem in Non-Small Cell Lung Cancer (NSCLC) To Identify Clinical Biomarkers of Therapy Response
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
The Innovation Office
InnovationMarketing@Moffitt.org
(813) 745-6828